ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/30/2024
Back to search
Official data from USPTO
INOGENIX AI-BASED BIOTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
10/30/2024
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
11/17/2020
Registration date
09/17/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/17/2024
Last transaction
09/17/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
03
Owner location
CHUNCHEON, GANGWON-DO, KR
Examiner
RINGLE, JIM
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the wording "INOGENIX" where the letters "INO" are in gray and letters "GENIX" are in blue. Below the wording are the words "AI-based BioTech" in gray in smaller font. Above the wording is a design consisting of a doughnut shape connected to a tear drop shape all in blue, and an independent disc shape shaded in blue above and to the right of the aforementioned shape. White represents the background and is not a feature of the mark.
Holders and representatives
Holders
INOGENIX INC.
INOGENIX Co., Ltd.
Representatives
Jae Youn Kim NOVICK, KIM & LEE, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations for medical purposes; medical diagnostic reagents; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for treating diseases of the metabolic systemcancerauto-immune disordersinfectious diseasesinflammatory diseasesneurological and genetic disordersbowel diseasesdigestive disorders and dermatological conditions; veterinary preparations for treating pets for treating diseases of the metabolic systemcancerauto-immune disordersinfectious diseasesinflammatory diseasesneurological and genetic disordersbowel diseasesdigestive disorders and dermatological conditions
Publications
History of USPTO decisions and trademark events.
34 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/17/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
09/17/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/02/2024
PUBO
PUBLISHED FOR OPPOSITION
07/02/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/12/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/29/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/28/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/28/2024
ALIE
ASSIGNED TO LIE
05/28/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12/26/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
10/24/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
10/24/2023
CNSI
SUSPENSION INQUIRY WRITTEN
10/24/2023
DOCK
ASSIGNED TO EXAMINER
05/02/2023
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
04/26/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
03/20/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/27/2022
GNSL
LETTER OF SUSPENSION E-MAILED
07/27/2022
CNSL
SUSPENSION LETTER WRITTEN
07/27/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/22/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/02/2021
GNSL
LETTER OF SUSPENSION E-MAILED
12/02/2021
CNSL
SUSPENSION LETTER WRITTEN
12/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/03/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/03/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/06/2021
GNRT
NON-FINAL ACTION E-MAILED
05/06/2021
CNRT
NON-FINAL ACTION WRITTEN
05/06/2021
DOCK
ASSIGNED TO EXAMINER
04/28/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/16/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/15/2021
NWAP
NEW APPLICATION ENTERED
11/20/2020
Continuous trademark protection
Get notified about every new filing that threatens INOGENIX AI-BASED BIOTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.